There are 129 papers on AMH in aging research: 7 trials and 60 observational studies in people, 31 in animals, 1 in cells, 29 reviews. The newest story, Oct 30, 2026: “Activating a protein improved egg quality in aged mice”.
Mice and humans: a single group. Cells and worms or flies: nothing yet.
C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.
Labs are independent when their papers share no last author and no institution.
Includes the processes named after it and trials of drugs aimed at it.
7 independent labs in 6 countries
Funders: Health Research Council of New Zealand and others
Human trial7
Humans60
Animals31
Cells1
In silico1
Interventions
1
Ovarian stromal stem cells
↑upin rats1
1 study
Ovarian stromal stem cells increase AMH in rats (P=0.02).
“IGF-1 and AMH expression were significantly higher in the OSC group than in controls (P=0.02)”
AMH is associated with reactive hyperemia index in humans (coefficient 0.052, 95% CI 0.008-0.096, P = .02).
“RHI as a continuous outcome was significantly positively associated both with antimüllerian hormone (AMH) and antral follicle count (AFC) on fully adjusted models (AMH coefficient 0.052; 95% CI, 0.008-0.096; P = .02”
AMH is linked with a lower risk of breast cancer in humans (OR = 0.80; 95% CI, 0.69-0.94).
“A 1-SD incremental increase in the anti-Müllerian hormone (AMH) level was associated with a higher risk of endometrial cancer [OR = 1.27; 95% confidence interval (CI), 1.05-1.54] but a lower risk of breast cancer (OR = 0.80; 95% CI, 0.69-0.94).”
AMH is linked with a higher risk of endometrial cancer in humans (OR = 1.27; 95% CI, 1.05-1.54).
“A 1-SD incremental increase in the anti-Müllerian hormone (AMH) level was associated with a higher risk of endometrial cancer [OR = 1.27; 95% confidence interval (CI), 1.05-1.54]”
AMH is linked with a lower risk of postmenopausal status in humans (values ≥ vs. <0.012 ng/mL) (OR = 0.225, 95%CI: 0.098-0.529, p < 0.001).
“postmenopausal stage associated with age (OR = 1.320, 95%CI: 1.084-1.320) and AMH (values ≥ vs. <0.012 ng/mL, OR = 0.225, 95%CI: 0.098-0.529, p-value < 0.001).”
Humansvalues ≥ vs. <0.012 ng/mL24 monthsfemalesn = 180
In a 21-day experiment, female mice aged 56–62 weeks showed improved egg quality and early embryo development after treatment that activated a metabolic regulator.In a 21-day experiment, female mice aged 56–62 weeks showed improved egg quality and early embryo development after treatment that activated a metabolic regulator.